Elevated Serum Regulator of Calcineurin 2 is Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated Serum Regulator of Calcineurin 2 is Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-16
DOI
10.3389/fphar.2022.840764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rab2A regulates the progression of nonalcoholic fatty liver disease downstream of AMPK-TBC1D1 axis by stabilizing PPARγ
- (2022) Zi-Yue Chen et al. PLOS BIOLOGY
- NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
- (2021) Eleonora Mammarella et al. Biology Direct
- PPARγ-Induced Global H3K27 Acetylation Maintains Osteo/Cementogenic Abilities of Periodontal Ligament Fibroblasts
- (2021) Hang Yuan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Association Between Coffee Consumption and Nonalcoholic Fatty Liver Disease in the South Korean General Population
- (2021) Li‐Juan Tan et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Long non-coding RNA MALAT1 silencing elevates microRNA-26a-5p to ameliorate myocardial injury in sepsis by reducing regulator of calcineurin 2
- (2021) Yuanyuan Luo et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Natural history of NASH and HCC
- (2020) Francesco Negro LIVER INTERNATIONAL
- Caloric Restriction Exacerbates Angiotensin II–Induced Abdominal Aortic Aneurysm in the Absence of p53
- (2019) Peng Gao et al. HYPERTENSION
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Clinicopathological significance of RCAN2 production in gastric carcinoma
- (2018) Yui Hattori et al. HISTOPATHOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- A disputed evidence on obesity: comparison of the effects of Rcan2−/− and Rps6kb1−/− mutations on growth and body weight in C57BL/6J mice
- (2016) Jing Zhao et al. Journal of Zhejiang University-SCIENCE B
- KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer
- (2016) H Niitsu et al. Oncogenesis
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Inactivation of the Rcan2 Gene in Mice Ameliorates the Age- and Diet-Induced Obesity by Causing a Reduction in Food Intake
- (2011) Xiao-yang Sun et al. PLoS One
- Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in aPPARα-dependent Manner
- (2010) Andrew C. Adams et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010
- (2010) Jian Gao FAN et al. Journal of Digestive Diseases
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started